On Monday, in the course of current trade, Shares of Campbell Soup Company (NYSE:CPB), climbed 0.15%, and is now trading at $47.88.
Campbell Soup Company, invited interested shareholders, investors, members of the media and consumers to listen to and view the slides accompanying its fourth quarter and full-year fiscal 2015 earnings call, which will be webcast live over the Internet on Thursday, Sept. 3, 2015 at 8:30 a.m. EDT. The call will follow the company’s fourth quarter and full-year fiscal 2015 earnings release, which it plans to distribute earlier the same day.
Campbell Soup Company, together with its subsidiaries, manufactures and markets convenience food products. It operates through U.S. Simple Meals; Global Baking and Snacking; International Simple Meals and Beverages; U.S. Beverages; and Bolthouse and Foodservice segments.
During an Afternoon trade, Shares of Lumber Liquidators Holdings Inc (NYSE:LL), dipped -0.40%, and is now trading at $14.87.
Lumber Liquidators, declared the hiring of Jill Witter as the Company’s Chief Compliance and Legal Officer. Ms. Witter will report directly to Founder and Acting Chief Executive Officer, Thomas D. Sullivan, and has been consulting and advising the Company’s Compliance team since early July.
Ms. Witter brings with her a deep background in compliance and legal experience in forest products, serving as General Counsel at Rayonier Inc. and the Forest Resources Division of the International Paper Company. Under her leadership as General Counsel and Ethics and Compliance Officer at Novation LLC, the company earned the Ethics inside Certification from the Ethisphere Institute and was named to Ethisphere’s lists of the World’s Most Ethical Companies for the past three years.
Lumber Liquidators Holdings, Inc., together with its subsidiaries, operates as a multi-channel specialty retailer of hardwood flooring, and hardwood flooring enhancements and accessories.
Shares of SUPERVALU INC. (NYSE:SVU), during its Monday’s current trading session gained 0.12%, and is now trading at $8.26.
In keeping with its commitment to make it easier for families to live well and within their budgets, the Wild Harvest brand, part of the SUPERVALU family of private brands, today announced plans to make 100 percent of its shell eggs cage-free by year-end.
“The Wild Harvest brand is focused on providing consumers with affordable, organic and free-from products sourced from farmers, ranchers and suppliers dedicated to environmentally and socially conscious practices,” said David Young, SUPERVALU’s vice president of private brands. “Our decision to move toward exclusively cage-free eggs is just one more way we are expanding that commitment.”
The Wild Harvest brand annually sells more than 38 million eggs under 12 different product varieties or SKUs. Earlier this year, the brand introduced a new 18-count cage-free egg, as well as a free-range, Non–GMO Project-verified 12-count egg product.
Wild Harvest products are available at SUPERVALU retail banners, including CUB Foods, FARM FRESH FOOD & PHARMACY, HORNBACHER’S, SHOP ‘N SAVE and SHOPPERS FOOD & PHARMACY, as well as independent grocery retailers nationwide.
SUPERVALU INC., together with its subsidiaries, operates as a grocery wholesaler and retailer in the United States. The company operates through three segments: Independent Business, Save-A-Lot, and Retail Food.
Finally, Illumina, Inc. (NASDAQ:ILMN), lost -0.95% Monday.
Illumina, declared it has signed a definitive agreement to acquire GenoLogics Life Sciences Software, a developer of industry-leading laboratory information management systems (LIMS) for life sciences organizations. The acquisition strengthens Illumina’s industry leading portfolio of genetic analysis solutions.
“The acquisition of GenoLogics demonstrates Illumina’s commitment to drive the adoption of sequencing in new markets and improve the genomic information workflow,” said Francis deSouza, President of Illumina. “Adding GenoLogics’ products to Illumina’s portfolio is another example of our continued commitment to bring innovative sample-to-answer solutions to research and clinical labs.”
Adopted by over 120 genomic labs worldwide, GenoLogics’ Clarity LIMS™ software enables lab efficiencies and improved sample throughput with increased accuracy, fast turnaround, sample traceability, and preconfigured instrument integrations. GenoLogics has a number of current partnerships with Illumina, including the recently launched Clarity LIMS X, an edition of its industry-leading laboratory informatics platform that is optimized for use with Illumina SeqLab to address population-scale genomics workflows.
Illumina, Inc. provides sequencing and array-based solutions for genetic analysis in North America, Europe, Latin America, the Asia-Pacific, the Middle East, and South Africa. The company’s products include sequencing platforms that are based on its SBS technology, which provides researchers with various ranges of applications and the ability to sequence mammalian genomes; and array platforms consist of HiScan and iScan systems, as well as NextSeq 550 system that are array scanners for DNA and RNA analysis applications, including single nucleotide polymorphism genotyping, copy number variations analysis, gene expression analysis, and methylation analysis.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
